- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Dan Malone Highlights the Key Strength of ISPOR's Annual Meeting
The international representation and participation at the ISPOR 20th Annual Meeting was one of the key aspects of the meeting, held May 18-20 in Philadelphia, Pennsylvania, said Dan Malone, PhD, RPh, incoming president of ISPOR.
The international representation and participation at the ISPOR 20th Annual Meeting was one of the key aspects of the meeting, held May 18-20 in Philadelphia, Pennsylvania, said Dan Malone, PhD, RPh, incoming president of ISPOR.
"It's fantastic to get scholars available from various countries all the way from Africa to Asia, Europe, Latin America, all to come to a meeting with some of the brightest minds in healthcare and outcomes research," he said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
